The SARS-CoV-2 envelope and membrane proteins modulate maturation and retention of the spike protein, allowing assembly of virus-like particles
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
No abstract available
Article activity feed
-
SciScore for 10.1101/2020.08.24.260901: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources Antibodies: Mouse anti-actin (clone AC74, Sigma-Aldrich), rabbit anti-SARS-CoV2 S2, mouse anti-SARS-CoV2 S1 and mouse anti-SARS-CoV2 N (Sino Biological), mouse anti-GFP (Roche), anti-VSV-G 41A1 and rabbit anti-GM130 (clone EP892Y, Abcam) were used according to the providers’ instructions. anti-actinsuggested: Noneanti-SARS-CoV2suggested: NoneS1suggested: Noneanti-SARS-CoV2 Nsuggested: Noneanti-GFPsuggested: Noneanti-VSV-Gsuggested: NoneAfter a saturation … SciScore for 10.1101/2020.08.24.260901: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources Antibodies: Mouse anti-actin (clone AC74, Sigma-Aldrich), rabbit anti-SARS-CoV2 S2, mouse anti-SARS-CoV2 S1 and mouse anti-SARS-CoV2 N (Sino Biological), mouse anti-GFP (Roche), anti-VSV-G 41A1 and rabbit anti-GM130 (clone EP892Y, Abcam) were used according to the providers’ instructions. anti-actinsuggested: Noneanti-SARS-CoV2suggested: NoneS1suggested: Noneanti-SARS-CoV2 Nsuggested: Noneanti-GFPsuggested: Noneanti-VSV-Gsuggested: NoneAfter a saturation step with 3% BSA/PBS, cells were incubated for 1 hour with rabbit anti-GM130 and mouse anti-SARS-CoV2 S1 antibodies at 1/200 dilution in 1% BSA/PBS, washed 3 times with 1%BSA/PBS, and stained for 1 hour with donkey anti-rabbit AlexaFluor-488 and donkey anti-mouse AlexaFluor-555 secondary antibodies (Molecular Probes) diluted 1/2,000 in 1% BSA/PBS. anti-GM130suggested: Noneanti-SARS-CoV2 S1suggested: Noneanti-rabbitsuggested: Noneanti-mousesuggested: NoneExperimental Models: Cell Lines Sentences Resources Supernatant fluids were collected after two days at 37°C, clarified by centrifugation (400xg, 5min), aliquoted and titrated in plaque forming unit by classic dilution limit assay on the same Vero E6 cells. Vero E6suggested: RRID:CVCL_XD71)VSV-Gts analysis: Huh7.5 cells were seeded 16h prior to transfection with pEGFP-N3-VSV-Gts and p7-encoding plasmid using GeneJammer transfection reagent (Agilent). Huh7.5suggested: RRID:CVCL_7927)Analysis of expression different proteins in cell lysate and pellet: HEK293T cells were seeded 24h prior to transfection with the different plasmids (2μg of each plasmid for a 10cm dish) using calcium phosphate precipitation. HEK293Tsuggested: NoneSoftware and Algorithms Sentences Resources Images were analyzed with the ImageJ software (imagj.nih.gov) and the Manders’ overlap coefficients were calculated by using the JACoP plugin. ImageJsuggested: (ImageJ, RRID:SCR_003070)Statistical analysis: Significance values were calculated by applying the Kruskal-Wallis test and Dunn’s multiple comparison test using the GraphPad Prism 6 software (GraphPad Software, USA). GraphPad Prismsuggested: (GraphPad Prism, RRID:SCR_002798)GraphPadsuggested: (GraphPad Prism, RRID:SCR_002798)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-
-